Insiders · Profile

Scannell Timothy J

Director at NovoCure · Director at Insulet · President and COO at Stryker. Filing since 23 Feb 2011. CIK 0001451533

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jun 2026
Director
Sold at will
2,945
$46.44K
17.1%
3 Jun 2025
Director
Sold at will
999
$17.30K
14.2%
10 Sep 2024
Director
Sold at will
5,000
$1.13M
14.1%
10 Jun 2024
Director
Sold at will
7,000
$1.33M
16.4%
4 Jun 2024
Director
Sold at will
964
$23.03K
24.5%
28 May 2024
Director
Sold at will
3,300
$596.97K
7.2%
23 Nov 2020
President and COO
Sold, plan not stated
5,000
$1.16M
2.3%
18 Nov 2019
President and COO
Sold, plan not stated
4,666
$962.51K
2.9%
16 Oct 2019
President and COO
Sold, plan not stated
4,666
$1.00M
2.9%
17 Sep 2019
President and COO
Sold, plan not stated
4,666
$1.02M
2.9%
16 Aug 2019
President and COO
Sold, plan not stated
4,666
$1.01M
2.9%
16 Jul 2019
President and COO
Sold, plan not stated
4,666
$960.66K
3.0%
18 Jun 2019
President and COO
Sold, plan not stated
4,666
$922.39K
3.0%
16 May 2019
President and COO
Sold, plan not stated
4,666
$871.21K
3.0%
16 Apr 2019
President and COO
Sold, plan not stated
4,666
$897.73K
3.0%
18 Mar 2019
President and COO
Sold, plan not stated
4,666
$901.83K
3.4%
19 Feb 2019
President and COO
Sold, plan not stated
4,666
$869.04K
3.4%
16 Jan 2019
President and COO
Sold, plan not stated
5,282
$863.59K
3.9%
18 Dec 2018
President and COO
Sold, plan not stated
9,332
$1.51M
6.6%
2 May 2017
Group President
Sold, plan not stated
13,322
$1.81M
10.4%
31 May 2016
Group President
Sold, plan not stated
9,945
$1.10M
10.0%
15 May 2015
Director
Bought
3,500
$94.68K
40.6%
4 Feb 2014
Group President
Sold, plan not stated
7,500
$576.28K
20.3%
5 Feb 2013
Group President
Sold, plan not stated
1,200
$75.35K
4.4%
23 Feb 2011
Group President
Sold, plan not stated
3,288
$203.50K
20.4%
25 decisions on file.